Please provide your email address to receive an email when new articles are posted on . “We designed the EBBINGHAUS study ... to assess the following hypothesis: [Did] the addition of evolocumab to ...

Past study results had raised concerns about the effect of lipid-lowering drugs like evolocumab on cognitive function, but the EBBINGHAUS trial presented at the American College of Cardiology 66th ...

WASHINGTON, DC — Taking the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor evolocumab (Repatha, Amgen) on top of statins does not affect memory or other cognitive problems—at least ...

Many of the concepts and methodologies that dominate contemporary studies of learning and memory were developed around the turn of the twentieth century. It was in this 'golden age' that German ...